Alloy Therapeutics
The Venture Partner at 82VS will collaborate with founders, scientists, and investors to build and scale early-stage biotech companies from idea to Series A or M&A. This role focuses on developing next-generation antibody-oligo conjugate companies, managing operational and strategic aspects, and leading portfolio companies through financing and transactions. The position requires a strong background in biomedical research, drug discovery, and venture creation within a dynamic startup environment.
Headquarters
Lexington, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Alloy Therapeutics is a fully integrated Product Development Organization (PDO) that partners with biotech, pharma, academic, and sovereign organizations to advance drug discovery and development across multiple modalities, including antibodies and multispecifics, TCR mimics, genetic medicines, pharmacology, and cell therapies. The company leverages proprietary AI/ML platforms, real-world data, and tech-enabled services spanning discovery through clinical development to deliver therapeutics with speed and capital efficiency. Alloy also operates specialized subsidiaries, including 82VS for asset-centric venture building and Spannerwerks for early clinical development support.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alloy Therapeutics.
Venture Ecosystem Principal
Redesign Health
Venture Builder [NTUitive]
Nanyang Technological University
Corporate Associate | Emerging Companies, Venture Capital
Advocates Legal Recruiting
Emerging Companies & Venture Capital Associate Attorney
Db_b875d025731feea5a308bba40eb6e1b7
Venture Designer
Founders Factory
Emerging Companies & Venture Capital Associate
Db_b875d025731feea5a308bba40eb6e1b7